Acomplia

      Acomplia  is a cannabinoid receptor blocker used for the treatment of obesity in patients that did not manage to obtain stable results from trying to lose weight using other methods. Acomplia is known to work by switching off certain brain circuits responsible for the feeling of hunger in people who smoke cannabis. Acomplia therefore decreases the overactivity of the endocannabinoid system that plays a very important role in regulating body weight, controlling the metabolism of lipid and glucose as well as energy balance. Acomplia is not a cure for obesity that will help the patient diagnosed with this condition to lose all the extra weight without any effort whatsoever – this medicine simply reduced food cravings, making it easier to do with less amounts of food. Acomplia is complementary to a healthy diet and regular exercise – in fact, the whole lifestyle of a person intending to take this medicine should be revised to make sure they benefit the most. The company producing Acomplia – Sanofi-Avensis – has also claimed this medicine helps to reduce nicotine cravings and improves a wide array of other cardio-metabolic factors when taken regularly.